江苏龙网

  1. 首页 > 人文 > >

果壳|人类找到癌症的解药了吗？( 四 )


[14] Xin Yu J, et al. Trends in clinical development for PD-1/PD-L1 inhibitors. Nat Rev Drug Discov. 2020;19(3):163-164. doi:10.1038/d41573-019-00182-w
[15] Evaluate Pharma: Examining the Immunotherapy Landscape: 2020-2024 https://www.evaluate.com/cancer-immunotherapy-drug-classes-watch-2020-and-beyond
[16] 默沙东官网：First-Line Treatment With Merck’s KEYTRUDA? (pembrolizumab) Doubled Five-Year Survival Rate (31.9%) Versus Chemotherapy (16.3%) in Certain Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 (TPS ≥50%) https://www.merck.com/news/first-line-treatment-with-mercks-keytruda-pembrolizumab-doubled-five-year-survival-rate-31-9-versus-chemotherapy-16-3-in-certain-patients-with-metastatic-non-small-cell-lung-cance/
[17] 默沙东官网：Merck’s KEYTRUDA? (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Esophageal Cancer https://www.merck.com/news/mercks-keytruda-pembrolizumab-plus-chemotherapy-reduced-risk-of-death-by-27-versus-chemotherapy-as-first-line-treatment-for-locally-advanced-or-metastatic-esophageal-cancer/
【果壳商业科技传播部出品】


推荐阅读


上一篇：果壳|每当路过牙科诊所，我就心慌气短、头脑发晕、想上厕所……

下一篇：歼-20|歼-20进驻沿海空军基地，台专家：美军当年没做到，解放军更不可能！